Literature DB >> 18608565

Is there any association between high-density lipoprotein, insulin resistance and non-alcoholic fatty liver disease in obese children?

Dimitrios Papandreou1, Israel Rousso, Ipolliti Economou, Areti Makedou, Tatiana Moudiou, Pavlos Malindretos, Ifigenia Pidonia, Athina Pantoleon, Ioannis Mavromichalis.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is estimated to occur in about 50% of obese children. The purpose of this study is to examine the association of anthropometric, biochemical and liver indexes in obese children with and without NAFLD and its relation with insulin resistance (IR). Forty-three obese children participated in the study. NAFLD was diagnosed by ultrasonography. Liver indices (SGOT, SGPT), lipid profile, glucose and insulin levels were performed in all patients. IR was measured by means of the homeostasis model assessment and oral glucose insulin sensitivity. Among the 43 obese patients, 18/43 (41.8%) had NAFLD based on ultrasonography. Fifty percent of them had mild steatosis and 50% had moderate/severe steatosis. In logistic regression analysis of factors associated with NAFLD, homeostasis model assessment IR (ExpB, 1.607; 95% confidence interval, 1.058-2.440; P <0.02) and high-density lipoprotein (0.952; 95% confidence interval, 0.814-1.075; P <0.03) were the most significant. IR, as has already been proved, is associated with NAFLD. Furthermore, high-density lipoprotein levels seem to play an additional role in predicting NAFLD in obese children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18608565     DOI: 10.1080/09637480701780088

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  2 in total

1.  Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.

Authors:  Lucia Pacifico; Eleonora Poggiogalle; Vito Cantisani; Guendalina Menichini; Paolo Ricci; Flavia Ferraro; Claudio Chiesa
Journal:  World J Hepatol       Date:  2010-07-27

2.  Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance.

Authors:  Xiaohui Xu; Xiaoqiang Li; Gangyi Yang; Ling Li; Wenjing Hu; Lili Zhang; Hua Liu; Hongting Zheng; Minghong Tan; Danping Zhu
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.